Podnos Yale
Officer at STLN
- Sold, on record
- $277k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jul 14, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STLNStarling Oncology, Inc.Officer
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice STLNNoticeJun 8, 2026 2026
Filed to sell 23,451 shares ($114k)
Podnos Yale, Officer
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale STLNRoutineJun 8, 2026 same day
Sold 23,451 shares at $5.38 ($126k)
Podnos Yale, Chief Medical Officer
10b5-1 planSold 8.3% of holdings ($1.5M position)259,527 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice STLNNoticeJul 14, 2026 +36 days
Filed to sell 23,452 shares ($147k)
Podnos Yale, Officer
10b5-1 planFiling
- 4 Form 4 sale STLNRoutineJul 14, 2026 same day
Sold 23,452 shares at $6.41 ($150k)
Podnos Yale, Chief Medical Officer
10b5-1 planSold 8.3% of holdings ($1.8M position)259,527 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | Jul 16, 2026 | STLN | Chief Medical Officer | Form 4 sale | 23,452 | $150k | 8.3% | Routine | SEC |
| Jul 14, 2026 | Jul 14, 2026 | STLN | Officer | Form 144 notice | 23,452 | $147k | Notice | SEC | |
| Jun 8, 2026 | Jun 9, 2026 | STLN | Chief Medical Officer | Form 4 sale | 23,451 | $126k | 8.3% | Routine | SEC |
| Jun 8, 2026 | Jun 8, 2026 | STLN | Officer | Form 144 notice | 23,451 | $114k | Notice | SEC |